0000899243-20-010608.txt : 20200409
0000899243-20-010608.hdr.sgml : 20200409
20200409163319
ACCESSION NUMBER:		0000899243-20-010608
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20200407
FILED AS OF DATE:		20200409
DATE AS OF CHANGE:		20200409
REPORTING-OWNER:	
	OWNER DATA:	
		COMPANY CONFORMED NAME:			Carey John F
		CENTRAL INDEX KEY:			0001774272
	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38891
		FILM NUMBER:		20784842
	MAIL ADDRESS:	
		STREET 1:		200 MINUTEMAN ROAD
		STREET 2:		SUITE 302
		CITY:			ANDOVER
		STATE:			MA
		ZIP:			01810
ISSUER:		
	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TransMedics Group, Inc.
		CENTRAL INDEX KEY:			0001756262
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			1228
	BUSINESS ADDRESS:	
		STREET 1:		200 MINUTEMAN ROAD
		CITY:			ANDOVER
		STATE:			MA
		ZIP:			01810
		BUSINESS PHONE:		9785520900
	MAIL ADDRESS:	
		STREET 1:		200 MINUTEMAN ROAD
		CITY:			ANDOVER
		STATE:			MA
		ZIP:			01810
4
1
doc4.xml
FORM 4 SUBMISSION
    X0306
    4
    2020-04-07
    0
    
        0001756262
        TransMedics Group, Inc.
        TMDX
    
    
        
            0001774272
            Carey John F
        
        
            C/O TRANSMEDICS GROUP, INC.
            200 MINUTEMAN ROAD
            ANDOVER
            MA
            01810
            
        
        
            0
            1
            0
            0
            VP of Operations
        
    
    
        
            
                Common Stock
            
            
                2020-04-07
            
            
            
                4
                M
                0
                
            
            
                
            
            
                
                    2000
                
                
                    0.39
                
                
                    A
                
            
            
                
                    5200
                
            
            
                
                    D
                
            
        
        
            
                Common Stock
            
            
                2020-04-07
            
            
            
                4
                S
                0
                
            
            
                
            
            
                
                    2000
                
                
                    13.10
                    
                
                
                    D
                
            
            
                
                    3200
                
            
            
                
                    D
                
            
        
    
    
        
            
                Stock Option (Right to Buy)
            
            
                0.39
            
            
                2020-04-07
            
            
            
                4
                M
                0
                
            
            
                
            
            
                
                    2000
                
                
                    0.00
                
                
                    D
                
            
            
                
            
            
                2021-09-27
            
            
                
                    Common Stock
                
                
                    2000
                
            
            
                
                    6894
                
            
            
                
                    D
                
            
        
    
    
        The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.
        The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $13.00 to $13.83, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
        The option is fully vested.
    
    
    
        By:  /s/ Stephen Gordon, Attorney-in-Fact
        2020-04-09